Hypogonadotropic Hypogonadism
38
4
5
21
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
13.2%
5 terminated out of 38 trials
80.8%
-5.7% vs benchmark
21%
8 trials in Phase 3/4
48%
10 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 21 completed trials
Clinical Trials (38)
Opioid Antagonism in Hypogonadotropic Hypogonadism
The Molecular Basis of Inherited Reproductive Disorders
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Kisspeptin Administration Subcutaneously to Patients With IHH
A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.
Kisspeptin Administration in the Adult
Neuropeptides in Human Reproduction
A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937)
Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)
Hypothalamic-pituitary Dysfunction in Diabetes
A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial
Kisspeptin in the Evaluation of Delayed Puberty
Growing up With the Young Endocrine Support System (YESS!)
A 6 Month Safety Extension Study of MBGS205
Low Energy Availability and Pituitary Function (LEAP Study)
Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)